|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Doxazosin#Package and Label Display Panel]] |
| {{Doxazosin}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| PRINCIPAL DISPLAY PANEL FOR 1 MG 100s
| |
| | |
| Representative sample of labeling (see [[Doxazosin how supplied storage and handling|HOW SUPPLIED]]] section of complete listing):
| |
| APOTEX CORP.
| |
| | |
| NDC 60505-0093-0 Doxazosin Tablets, USP1mgRx100 count
| |
| | |
| {|
| |
| | [[image:doxa8.jpg|400px|thumb]]
| |
| |}
| |
| | |
| PRINCIPAL DISPLAY PANEL FOR 2 MG 100s
| |
| | |
| Representative sample of labeling (see [[Doxazosin how supplied storage and handling|HOW SUPPLIED]] section of complete listing):
| |
| APOTEX CORP.
| |
| | |
| NDC 60505-0094-0 Doxazosin Tablets, USP2mgRx100 count
| |
| {|
| |
| | [[image:doxa9.jpg|400px|thumb]]
| |
| |}
| |
| PRINCIPAL DISPLAY PANEL FOR 4 MG 100s
| |
| | |
| Representative sample of labeling (see [[Doxazosin how supplied storage and handling|HOW SUPPLIED]] section of complete listing):
| |
| APOTEX CORP.
| |
| | |
| NDC 60505-0095-0 Doxazosin Tablets, USP4mgRx100 count
| |
| {|
| |
| | [[image:doxa10.jpg|400px|thumb]]
| |
| |}
| |
| | |
| PRINCIPAL DISPLAY PANEL FOR 8 MG 100s
| |
| | |
| Representative sample of labeling (see [[Doxazosin how supplied storage and handling|HOW SUPPLIED]] section of complete listing):
| |
| APOTEX CORP.
| |
| | |
| NDC 60505-0096-0 Doxazosin Tablets, USP8mgRx100 count
| |
| | |
| {|
| |
| | |
| | [[image:doxa11.jpg|400px|thumb]]
| |
| | |
| |}
| |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOXAZOSIN TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b | publisher = | date = | accessdate = 7 March 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |